10x Genomics, Inc. (TXG)
After hours:
| Previous close | 26.39 |
| Open | 26.59 |
| Bid | 25.92 x 500 |
| Ask | 25.99 x 300 |
| Day's range | 25.87 - 27.40 |
| 52-week range | 24.60 - 63.57 |
| Volume | |
| Avg. volume | 1,612,716 |
| Market cap | 3.111B |
| Beta (5Y monthly) | 1.94 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
10x Genomics to Present at the BofA Securities 2024 Healthcare Conference
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that members of its management team will participate in a fireside chat at the BofA Securities 2024 Healthcare Conference on Tuesday, May 14, at 4:20 p.m. Pacific Time.
- PR Newswire
10x Genomics Reports First Quarter 2024 Financial Results
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first quarter ended March 31, 2024.
- PR Newswire
10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it will report financial results for the first quarter ended March 31, 2024 after market close on Tuesday, April 30, 2024. The company will host a public conference call and live webcast for analysts and investors beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. The news release with the financial results will be accessible fro
